当前位置:首页 - 行情中心 - 华北制药(600812) - 财务分析

华北制药

(600812)

  

流通市值:106.72亿  总市值:106.72亿
流通股本:17.16亿   总股本:17.16亿

华北制药(600812)财务分析

净利润 + 每股收益
------
  • 净利润(亿元)
  • 每股收益(元)

    截至2025年半年度实现净利润1.62亿元,每股收益0.07元。

股东权益 + 未分配利润
------
  • 股东权益(亿元)
  • 未分配利润(亿元)

    截至2025年半年度最新股东权益672425.25万元,未分配利润-45810.26万元。

总资产 + 负债
------
  • 总资产(亿元)
  • 负债(亿元)

    截至2025年半年度最新总资产2175294.20万元,负债1502868.96万元。

利润表
报告期2025-06-302025-03-312024-12-312024-09-30
营业总收入5,275,037,790.22,574,254,051.929,869,575,819.117,560,235,670.39
营业总成本5,064,452,841.412,469,225,602.079,602,162,210.857,395,586,299.65
其他经营收益
营业利润213,773,689.18102,915,436.03311,681,160.94223,095,087.57
利润总额214,036,244.45103,152,262.47309,832,512.76222,975,932.83
净利润162,286,856.676,625,661.99214,966,518.33146,440,745.71
每股收益
其他综合收益-412,469.0239,722.881,601,601.48-150,201.56
综合收益总额161,874,387.5876,665,384.87216,568,119.81146,290,544.15
资产负债表
报告期2025-06-302025-03-312024-12-312024-09-30
流动资产:
流动资产合计8,564,390,541.758,794,547,086.898,259,279,869.848,673,534,666.03
非流动资产:
非流动资产合计13,188,551,499.1713,199,484,516.5213,212,178,446.5913,033,256,575.06
资产总计21,752,942,040.9221,994,031,603.4121,471,458,316.4321,706,791,241.09
流动负债:
流动负债合计12,108,718,070.5612,025,521,079.6810,961,529,998.4211,077,549,321.96
非流动负债:
非流动负债合计2,919,971,517.193,216,638,803.663,835,315,230.434,023,658,383.88
负债合计15,028,689,587.7515,242,159,883.3414,796,845,228.8515,101,207,705.84
所有者权益(或股东权益):
归属于母公司股东权益合计5,467,083,266.955,447,527,540.655,389,402,984.115,364,370,475.41
股东权益合计6,724,252,453.176,751,871,720.076,674,613,087.586,605,583,535.25
负债和股东权益合计21,752,942,040.9221,994,031,603.4121,471,458,316.4321,706,791,241.09
现金流量表
报告期2025-06-302025-03-312024-12-312024-09-30
经营活动产生的现金流量:
经营活动现金流入小计3,545,924,571.691,634,519,3217,861,279,183.76,190,918,816.69
经营活动现金流出小计3,054,426,514.781,471,205,501.616,631,713,783.975,132,523,181.28
经营活动产生的现金流量净额491,498,056.91163,313,819.391,229,565,399.731,058,395,635.41
投资活动产生的现金流量:
投资活动现金流入小计60,008,20060,006,900511,985,618.041,256,500
投资活动现金流出小计235,625,353.31120,585,892.861,458,717,313.8481,875,355.35
投资活动产生的现金流量净额-175,617,153.31-60,578,992.86-946,731,695.76-480,618,855.35
筹资活动产生的现金流量:
筹资活动现金流入小计4,517,450,0001,976,350,00011,701,445,416.679,245,455,000
筹资活动现金流出小计5,031,506,160.341,963,386,231.4611,238,708,445.738,966,113,912.66
筹资活动产生的现金流量净额-514,056,160.3412,963,768.54462,736,970.94279,341,087.34
汇率变动对现金及现金等价物的影响3,877,130.092,527,048.3711,828,701.558,067,852.11
现金及现金等价物净增加额-194,298,126.65118,225,643.44757,399,376.46865,185,719.51
期末现金及现金等价物余额1,068,105,826.371,380,629,596.461,262,403,953.021,370,190,296.07
补充资料:
现金及现金等价物的净增加额-194,298,126.65-757,399,376.46-
TOP↑